IL-18 代谢重编程表达 CAR 的自然杀伤 T 细胞并增强其抗肿瘤活性
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity.
76.4分
★★★★☆
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 5
条件筛选 · 已选 3 项 · 共 5 条展开收起
阻断 TGF-β 信号通路是人 iPSC 来源 NK 细胞介导有效杀伤肝细胞癌的必要条件
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells.
64.0分
★★★☆☆
站内排序·非疗效
靶向 Lin28 轴增强 glypican-3-CAR-T 细胞对肝肿瘤起始细胞群的疗效
Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population.
62.9分
★★★☆☆
站内排序·非疗效
靶向 GPC3 的新型 NKp46-NK 细胞衔接器 CYT-303 的衍生与临床前表征
Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3.
47.2分
★★★☆☆
站内排序·非疗效
探索肝细胞癌中 Glypican-3 靶向 CAR-NK 治疗与潜在治疗耐药
Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma.
34.6分
★☆☆☆☆
站内排序·非疗效
共 5 条